AMTB vs RARE · P/E 16, rev $268.7M vs rev $350.0M
Amerant Bancorp Inc. (AMTB) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Amerant Bancorp Inc. (AMTB) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AMTB revenue for 2026-06-30 was $268.7M. Net income was $38.9M. AMTB currently screens at market cap $896.5M and trailing P/E 16.0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AMTB currently screens at market cap $896.5M and trailing P/E 16.0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AMTB and RARE stock pages for the full models.
Not investment advice.